These two reports address the effects of varicella-zoster ... vaccine recipients than among placebo recipients (0.6% vs. 0.4%), for unknown reasons. The review authors recommend vaccine ...
recombinant zoster vaccine (RZV) and adjuvanted quadrivalent formulation (aIIV4), among older adults. "From a safety standpoint, this study supports the simultaneous administration of RZV and ...
The investigators evaluated the impact of live attenuated zoster vaccination on stroke and MI risk in adults indicated for vaccination—those 50 years and older (93.02% of both the vaccinated ...
Sareen, PharmD The second dose of Shingrix (recombinant zoster vaccine) may cause side effects ... In 2017, the Food and Drug Administration (FDA) approved Shingrix for the prevention of shingles ...